|
|
|
Advertisement |
Introducing Cross-Trial LMS: A Simple, Efficient, and Intuitive Way to Send Bulk Training
On Demand
Learn More |
Regulatory |
 |
FDA Policies Support Shift to Decentralized Clinical Trials |
FDA Commissioner Scott Gottlieb supports approaches that help biomedical research "become more agile and efficient" and reduce the cost of developing therapies, including decentralized trials and how real world data (RWD) and real world evidence (RWE) to support a range of drug development goals.
... /Read more/ |
|
|
|
|
|
|
|